3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
56
Observational
2
Expanded_access
1
Sponsor
Cancer Type
Thoracic
21
Dermatologic
14
Gastrointestinal
13
Head & Neck
7
Genitourinary
5
Tumor-Agnostic
2
Other
1
CNS
1
Conditions
Neoplasms
1
Neoplasm Metastasis
1
Interventions
Surveys and Questionnaires
48
Blood Specimen Collection
22
Interviews as Topic
14
Data Collection
11
Magnetic Resonance Spectroscopy
6
Hematologic Tests
6
Specimen Handling
5
Restraint, Physical
5
Radiotherapy
5
Palliative Care
4
Observation
4
Mental Status and Dementia Tests
4
Watchful Waiting
3
Registries
3
Quality of Life
3
Phlebotomy
3
Neoadjuvant Therapy
3
Magnetic Resonance Imaging
3
Lapatinib
3
Immunotherapy
3
Immune Checkpoint Inhibitors
3
Health Records, Personal
3
Focus Groups
3
Drug Therapy
3
Bevacizumab
3
Absorptiometry, Photon
3
veliparib
2
talazoparib
2
rucaparib
2
pamiparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Nivolumab
×
Tumor-Agnostic
×
Clear all
NCT03963518
2025-10-06
SURROGATE-ICI
Institut Bergonié
Completed
631 enrolled
6 charts
NCT03453892
2023-02-16
ST-ICI
University of Erlangen-Nürnberg Medical School
Completed
150 enrolled